[1]
“Immunomodulation of cancer cells by CAR-T, mAbs, CTLA-4 and targeted neoantigens”, Acervo Saúde, vol. 15, no. 3, p. e9959, Mar. 2022, doi: 10.25248/reas.e9959.2022.